Ann‐Shing Lee
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- Head and Neck Cancer Studies 1
- Co-authors
- Jian-Ying Zhang (1 shared paper)Sang Min Yoon (1 shared paper)Jinsil Seong (1 shared paper)Zhao‐Chong Zeng (1 shared paper)Ka On Lam (1 shared paper)Jason Chia‐Hsien Cheng (1 shared paper)Yong Hu (1 shared paper)Philip Chong‐hei Kwok (2 shared papers)
- Journals
- Liver Cancer (3 papers)The Lancet (1 paper)Cancer (1 paper)Surgical Oncology (1 paper)HepatoBiliary Surgery and Nutrition (1 paper)
In The Last Decade
Ann‐Shing Lee
7 papers receiving 682 citations
Ann‐Shing Lee's Hit Papers
Peers
Comparison fields: 5 of 48
- Hepatology 443
- Oncology 120
- Otorhinolaryngology 18
- Pathology and Forensic Medicine 63
- Epidemiology 116
Countries citing papers authored by Ann‐Shing Lee
This map shows the geographic impact of Ann‐Shing Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Shing Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Shing Lee more than expected).
Fields of papers citing papers by Ann‐Shing Lee
This network shows the impact of papers produced by Ann‐Shing Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Shing Lee. The network helps show where Ann‐Shing Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann‐Shing Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study Hit paper breakdown → | 2023 | 514 |
| 2 | 2017 | 52 | |
| 3 | 2015 | 42 | |
| 4 | 2018 | 30 | |
| 5 | 2019 | 29 | |
| 6 | 2005 | 19 | |
| 7 | 2022 | 7 |
About Ann‐Shing Lee
Ann‐Shing Lee is a scholar working on Hepatology, Otorhinolaryngology, Oncology, Surgery and Insect Science, having authored 7 papers that have together received 693 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Head and Neck Surgical Oncology (1 paper), Ear and Head Tumors (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Hepatology (443 citations), Oncology (120 citations), Otorhinolaryngology (18 citations), Pathology and Forensic Medicine (63 citations) and Epidemiology (116 citations). Ann‐Shing Lee has collaborated with scholars based in China, Hong Kong and Taiwan. Frequent co-authors include Jian-Ying Zhang, Sang Min Yoon, Jinsil Seong, Zhao‐Chong Zeng, Ka On Lam, Jason Chia‐Hsien Cheng, Yong Hu, Philip Chong‐hei Kwok, Stephen Lam Chan and Thomas Chung Cheung Yau. Their work appears in journals such as Liver Cancer, The Lancet, Cancer, Surgical Oncology and HepatoBiliary Surgery and Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.